Clinical Validation of a Highly Sensitive GC-MS Platform for Routine Urine Drug Screening and Real-Time Reporting of up to 212 Drugs

Figure 3

Distribution of qualified hits across 99 retrospective patient samples used for clinical validation. The reference platform reported up to 15 drugs per patient while the new platform reported up to 20 drugs per patient. On an average, the reference platform reported 3–5 patients per sample while the new platform reported 6–8 patients per sample.